Share on LinkedInShare on LinkedIn

ARTICLE · 24 APRIL 2015

SCC Confirms Leave Test For Securities Class Actions Has Teeth

In the spring of 2010, Theratechnologies Inc. (Thera) was awaiting FDA approval of a new drug to reduce excess abdominal fat in HIV patients.

CanadaCorporate/Commercial Law

On April 17, 2015, the Supreme Court of Canada provided Canadian public companies with an important win, holding that the test for leave to start a class action for breach of a company's secondary market disclosure requires the court to evaluate the evidence and conclude that there is a reasonable and realistic chance that the action will succeed. In allowing the appeal of Theratechnologies Inc. and reversing the Québec Court of Appeal's decision granting authorization of a proposed class action under s. 225.4 of the Québec Securities Act (QSA), the Court recognized that since the purpose of the leave mechanism is to screen out unmeritorious lawsuits, the test for leave must have teeth and is not simply a "speed bump" on the way to certification. Although this does not require the court to conduct a "mini-trial" or undertake a full evaluation of the evidence, the plaintiff must nonetheless provide "a plausible analysis of the applicable legislative provisions" and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from